Public Market Listing
SOBINasdaq Stockholm
Live quotes, historical charts, and market capitalization for Swedish Orphan Biovitrum AB (publ) are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
2Total Assets
1Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | Interleukin-1 receptor (IL-1R) · Interleukin-1 receptor type 1 (IL-1R1)Protein / enzyme therapeutic | Rheumatoid Arthritis | |
Pegcetacoplan(Empaveli) | Phase 3 | Complement C3Peptide | Chronic Kidney Disease |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.